Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Coming to Rutgers–New Brunswick: Greatly Expanded Research Opportunities for Students.
- How Beetle Juice Led to the Discovery of a Virus and Solved the Mystery of a Superworm Die-Off.
- Researchers Examine the Persistence of Invisible Plastic Pollution.
- Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey.
- NJACTS Community Engagement Core Available Services
Categories
- Community (2,051)
- Covid (978)
- CTO Events (4)
- News (2,606)
- Pilots (20)